Medtronic has introduced positive results from the ENGAGE global registry study evaluating its Endurant AAA stent graft system.
According to the results, aneurysm-related mortality was 1.6 percent in the ENGAGE registry versus 6.3 percent for open surgery.
A lower rupture rate and decreased secondary intervention rate were also observed, according to Medtronic.
The results were presented at the 2016 Charing Cross Symposium in London. — Anisa Jibrell